• Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib

  • 2024/11/21
  • 再生時間： 19 分
  • ポッドキャスト

Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Interview with Hagop Kantarjian, MD, author of Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical Trial. Hosted by Vivek Subbiah, MD.

    Related Content:

    • Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib
    続きを読む 一部表示

あらすじ・解説

Interview with Hagop Kantarjian, MD, author of Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical Trial. Hosted by Vivek Subbiah, MD.

Related Content:

  • Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib
続きを読む 一部表示

Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminibに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。